Nis P Suppli1,2, Jens D Bukh2, Terrie E Moffitt3,4,5,6, Avshalom Caspi3,4,5,6, Christoffer Johansen1,7, Anne Tjønneland8, Lars V Kessing2, Susanne O Dalton1. 1. Survivorship, Danish Cancer Society Research Center, Copenhagen, Denmark. 2. Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. 3. Department of Psychology and Neuroscience, Duke University, NC, USA. 4. Department of Psychiatry and Behavioral Sciences, Duke University, NC, USA. 5. Center for Genomic and Computational Biology, Duke University, NC, USA. 6. Social, Genetic, and Developmental Psychiatry Research Center, Institute of Psychiatry, King's College London, London, UK. 7. Department of Oncology, Finsencentret, Rigshospitalet, Copenhagen, Denmark. 8. Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark.
Abstract
BACKGROUND: The role of gene-environment interactions in the pathogenesis of depression is unclear. Previous studies addressed vulnerability for depression after childhood adversity and stressful life events among carriers of numerous specific genetic variants; however, the importance of individual genetic variants, the environmental exposures with which they interact, and the magnitude of the risk conveyed by these interactions remain elusive. METHODS: We included 7,320 people with a first primary cancer identified in the prospective Diet, Cancer and Health study in an exposed-only cohort study. The mean age of the individuals was 68 years (5th, 95th percentiles: 58, 78) at cancer diagnosis. Using Cox regression models and cumulative incidence plots, we analyzed the associations between genetic variants in 5-HTTLPR, BDNF, HTR1A, COMT, and FKBP5 and use of antidepressants as well as hospital contact for depression after diagnosis of cancer. RESULTS: Overall, we observed no statistically significant associations, with nonsignificant hazard ratio estimates for use of antidepressants of 0.95-1.07. CONCLUSIONS: This study of elderly people indicates that it is unlikely that the investigated genetic variants are clinically relevantly associated with depression after diagnosis of cancer. The mechanisms for gene-environment interactions in younger individuals are probably different, and we advise caution in extrapolating our results to early life stress. However, conclusion from the present study might be generalizable to elderly persons exposed to other stressful life events.
BACKGROUND: The role of gene-environment interactions in the pathogenesis of depression is unclear. Previous studies addressed vulnerability for depression after childhood adversity and stressful life events among carriers of numerous specific genetic variants; however, the importance of individual genetic variants, the environmental exposures with which they interact, and the magnitude of the risk conveyed by these interactions remain elusive. METHODS: We included 7,320 people with a first primary cancer identified in the prospective Diet, Cancer and Health study in an exposed-only cohort study. The mean age of the individuals was 68 years (5th, 95th percentiles: 58, 78) at cancer diagnosis. Using Cox regression models and cumulative incidence plots, we analyzed the associations between genetic variants in 5-HTTLPR, BDNF, HTR1A, COMT, and FKBP5 and use of antidepressants as well as hospital contact for depression after diagnosis of cancer. RESULTS: Overall, we observed no statistically significant associations, with nonsignificant hazard ratio estimates for use of antidepressants of 0.95-1.07. CONCLUSIONS: This study of elderly people indicates that it is unlikely that the investigated genetic variants are clinically relevantly associated with depression after diagnosis of cancer. The mechanisms for gene-environment interactions in younger individuals are probably different, and we advise caution in extrapolating our results to early life stress. However, conclusion from the present study might be generalizable to elderly persons exposed to other stressful life events.
Authors: Henrik Rasmussen; Yu Bagger; Laszlo B Tanko; Claus Christiansen; Thomas Werge Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2009-06-05 Impact factor: 3.568
Authors: Anne Tjønneland; Anja Olsen; Katja Boll; Connie Stripp; Jane Christensen; Gerda Engholm; Kim Overvad Journal: Scand J Public Health Date: 2007 Impact factor: 3.021
Authors: Hyo Jung Kang; Yuka Imamura Kawasawa; Feng Cheng; Ying Zhu; Xuming Xu; Mingfeng Li; André M M Sousa; Mihovil Pletikos; Kyle A Meyer; Goran Sedmak; Tobias Guennel; Yurae Shin; Matthew B Johnson; Zeljka Krsnik; Simone Mayer; Sofia Fertuzinhos; Sheila Umlauf; Steven N Lisgo; Alexander Vortmeyer; Daniel R Weinberger; Shrikant Mane; Thomas M Hyde; Anita Huttner; Mark Reimers; Joel E Kleinman; Nenad Sestan Journal: Nature Date: 2011-10-26 Impact factor: 49.962
Authors: Emma S Nyman; Sonja Sulkava; Pia Soronen; Jouko Miettunen; Anu Loukola; Virpi Leppä; Matti Joukamaa; Pirjo Mäki; Marjo-Riitta Järvelin; Nelson Freimer; Leena Peltonen; Juha Veijola; Tiina Paunio Journal: BMJ Open Date: 2011-08-27 Impact factor: 2.692
Authors: Ricardo Araya; Xianzhang Hu; Jon Heron; Mary-Anne Enoch; Jonathan Evans; Glyn Lewis; David Nutt; David Goldman Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2009-07-05 Impact factor: 3.568